Redeye provides an update following Truecaller’s Q1 2026 results, in which net sales provided a slig...
Investors House's Q1 report was burdened by one-off costs, and both the Real Estate and Services seg...
Redeye retains its positive view of Freja following the Q1 report.
Q1 net sales and adjusted EBITDA were slightly below our expectations.
Q1 adjusted EBITDA was clearly higher and adjustment items significantly lower than we forecast.
* Strong margins (19% adj. EBIT margin), improved ACV * We raise '26e/'27e/'28e EBIT by 20%/6%/5% on...
Etteplan's Q1 was clearly softer than expected, with all three service areas missing our EBITA estim...
Premium Snacks levererade ett starkt Q1’26 med en tillväxt om 17,9 % och förbättrad lönsamhet, trots...
Redeye comments on the acquisition of Superior and the directed rights issue.
Redeye comments on Active Biotech's first quarter report.
LAIQON’s first Q1 26 KPI release on 27 April showed continued AuM momentum, while profitability rema...
Redeye updates its estimates and valuation after Boreo’s Q1 2026 report.
* Sales of SEK 72m (-5% vs. ABGSCe 76), a 35% y-o-y growth * Order book at a record, and ARR up 6% *...
Redeye provides its initial take on Navigo’s Q1 2026 report, which came in slightly below our sales ...
Redeye comments on Fractal Gaming Group’s Q1 2026 report, released this morning, which came in below...
* Big deviations in a seasonally smaller quarter * Strong orders de-risks '26e in our view * Estimat...
Redeye comments on Ferroamp’s Q1 report, in which sales grew 74% y-o-y.
Suominen Q1 comparable EBITDA of EUR 2.2m came 33% below Vara Research consensus expectations.
Redeye considers I-Tech’s Q1 report to be very solid, with an FX-adjusted growth of 7% y/y despite t...
* Orders +20%, sales +14%, adj. EBITA +10% vs. ABGSCe * Enedo sees strong orders, growth and margin ...
